TELO

Telomir Pharmaceuticals, Inc.

Healthcare · Biotechnology

$132.00 sample

+0.80 (+0.61%) 1D

Market cap

$151.2B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-16

Alerts

8

Price$132.00 +1.84% 3M daily closessample

138.28128.52

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: 10% owner
Sep 22INSInsider sell: 10% owner
Sep 16SEC10-Q filed
Sep 10INSInsider sell: Chief Executive Officer
Sep 03SECForm 144 filed
Aug 25INSInsider sell: 10% owner
Aug 19INSInsider sell: General Counsel
Aug 11INSInsider buy: EVP, Operations

Sign up to see the real TELO record →

Company facts

SEC EDGAR registration

Name: Telomir Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +41sample, -100 to +100
Reporting currency: USD

Who is positioning in TELO

sample

Insiders: 35 insider transactions over 90 days, net selling, $294.8M
Congress: 5 members traded over 90 days
Institutions · 13F: 30 funds hold $3.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$4.2B +20.0% y/y

Q4 2024Q3 2026

Inventory$2.4B +17.1% y/y

Q4 2024Q3 2026

Accounts receivable$1.8B +5.9% y/y

Q4 2024Q3 2026

Total debt$5.1B +17.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $39.7B +4.3% 3M
Sample peer B: $144.7B +5.5% 3M
Sample peer C: $130.5B -13.4% 3M
Sample peer D: $137.7B +6.9% 3M
Sample peer E: $140.8B -12.3% 3M